Abstract：Objective To compare the efficacy of insulin liproline and biosynthetic human insulin in patients with gestational diabetes mellitus(GDM).Methods A total of 98 cases of GDM patients who need insulin treatment in Foshan Chancheng District Central Hospital Chancheng District Central Hospital from December 2019 to December 2020 were selected and randomly divided into the study group(n=49)and the control group(n=49)according to the random number table method.The study group was treated with liproline insulin and the control group was treated with biosynthetic human insulin.Blood glucose levels and pregnancy outcomes were compared between the two groups before and after treatment.Results There was no significant difference in fasting blood glucose(FPG),2 h postprandial blood glucose(2 h PG),glycosylated hemoglobin(HbA1c)and insulin resistance index(HOMA-IR)between the two groups before treatment(P>0.05).There was no significant difference in the incidence of postpartum ketosis and postpartum hemorrhage between the two groups after treatment(P>0.05).After treatment,the FPG,2 h PG,HbA1c and HOMA-IR of the study group were lower than those of the control group,the incidence of premature delivery,hyperhydramnios and cesarean section were lower than those of the control group,the incidence of neonatal macrosomia,hyperbilirubinemia,hypoglycemia and fetal distress were lower than those of the control group,and the differences were statistically significant(P<0.05).Conclusion Insulin lispro in the treatment of GDM can effectively reduce the blood glucose level,improve the incidence of adverse pregnancy outcomes,reduce neonatal complications,and the clinical effect is better than that of biosynthetic human insulin,which is worthy of clinical promotion.
Edsm A，Jljm B，Bem C.Gestational Diabetes Mellitus[J].Endocrinol Metab Clin North Am，2019，48（3）：479-493.
[2]
Eades CE，Cameron DM，Evans J.Prevalence of gestational diabetes mellitus in Europe：A meta-analysis[J].Diabetes Res Clin Pract，2017，129：173-181.
[3]
Al-Rifai RH，Faisal A.Prevalence of type 2 diabetes，prediabetes，and gestational diabetes mellitus in women of childbearing age in Middle East and North Africa，2000-2017：protocol for two systematic reviews and meta-analyses[J].Syst Rev，2018，7（1）：96.
[4]
Larrabure-Torrealva G T，Stephanie M，Angel LFM，et al.Prevalence and risk factors of gestational diabetes mellitus：findings from a universal screening feasibility program in Lima，Peru[J].BMC Pregnancy Childbirth，2018，18（1）：303.
Malyszko J.Mechanism of endothelial dysfunction in chronic kidney disease[J].Clin Chim Acta，2010，411（19-20）：1412-1420.
[6]
Farrar D，Simmonds M，Bryant M，et al.Hyperglycaemia and Risk of Adverse Perinatal Outcomes：Systematic Review and Meta-analysis[J].Obstetric Anesthesia Digest，2017，37（2）：64-65.
[7]
Reece EA，Gustavo Leguizamón，Wiznitzer A.Gestational diabetes：the need for a common ground[J].Lancet，2009，373（9677）：1789-1797.
[9]
Cao W，Wang X，Chen T，et al.Maternal lipids，BMI and IL-17/IL-35 imbalance in concurrent gestational diabetes mellitus and preeclampsia[J].Exp Ther Med，2018，16（1）：427-435.
[10]
Herrera Martínez A，Palomares Ortega R，Bahamondes Opazo R，et al.Hyperlipidemia during gestational diabetes and its relation with maternal and offspring complications[J].Nutr Hosp，2018，35（3）：698-706.
[12]
Izumi S，Muano T，Mori A，et al.Common carotid artery stiffness，cardiovascular function and lipid metabolism after menopause[J].Life Sci，2012，78（15）：1696-1701.
[13]
Koppen AV，Verschuren L，Hoek AMVD，et al.Uncovering a Predictive Molecular Signature for the Onset of NASHRelated Fibrosis in a Translational NASH Mouse Model[J].Cell Mol Gastroenterol Hepatol，2017，5（1）：83-98.
[14]
NRgaard K，Sukumar N，Rafnsson SB，et al.Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes：Systematic Review and Meta-Analysis[J].Diabetes Ther，2018，9（3）：891-917.
京公网安备 11010502046607号